Related Experiment Videos
p53-independent functions of the p19(ARF) tumor suppressor
J D Weber1, J R Jeffers, J E Rehg
1Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Abstract:
The p19(ARF) tumor suppressor antagonizes Mdm2 to induce p53-dependent cell cycle arrest. Individual TKO (triple knock out) mice nullizygous for ARF, p53, and Mdm2 develop multiple tumors at a frequency greater than those observed in animals lacking both p53 and Mdm2 or p53 alone, demonstrating that p19(ARF) can act independently of the Mdm2-p53 axis in tumor surveillance. Reintroduction of ARF into TKO mouse embryo fibroblasts (MEFs), but not into those lacking both p53 and ARF, arrested the cell division cycle in the G1 phase. Inhibition of the retinoblastoma protein had no effect on the ability of ARF to arrest TKO MEFs. Thus, in the absence of Mdm2, p19(ARF) interacts with other targets to inhibit cell proliferation.
Insights
The tumor suppressor p19(ARF) prevents tumor growth independently of the Mdm2-p53 pathway. ARF halts cell division in mouse cells lacking Mdm2, indicating alternative targets for its tumor-suppressive functions.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p19(ARF) protein is a known tumor suppressor that functions by antagonizing Mdm2, leading to p53-dependent cell cycle arrest.
- Triple knockout (TKO) mice lacking ARF, p53, and Mdm2 exhibit higher tumor incidence than mice lacking only p53 and Mdm2 or p53 alone.
Purpose of the Study:
- To investigate the independent role of p19(ARF) in tumor surveillance beyond the Mdm2-p53 pathway.
- To determine the mechanism by which ARF suppresses tumor formation in the absence of Mdm2.
Main Methods:
- Generation and analysis of triple knockout (TKO) mice lacking ARF, p53, and Mdm2.
- Reintroduction of ARF into mouse embryo fibroblasts (MEFs) from TKO mice and p53/ARF knockout mice.
- Cell cycle analysis (G1 phase arrest) and assessment of retinoblastoma protein function.
Main Results:
- TKO mice developed tumors more frequently than mice lacking only p53 and Mdm2 or p53 alone, confirming ARF's independent tumor surveillance role.
- ARF reintroduction into TKO MEFs, but not p53/ARF-deficient MEFs, caused G1 phase cell cycle arrest.
- The cell cycle arrest induced by ARF in TKO MEFs was independent of retinoblastoma protein inhibition.
Conclusions:
- p19(ARF) possesses tumor suppressor functions that operate independently of the canonical Mdm2-p53 signaling axis.
- In the absence of Mdm2, p19(ARF) utilizes alternative molecular targets to inhibit cell proliferation and prevent tumor development.